When developing a plan of care for a patient with acute myelogenous leukemia (AML), the oncology nurse should keep in mind that:
A) consolidation therapy uses low-dose chemotherapy to maintain remission.
B) induction therapy reduces the leukemic cell burden.
C) consolidation therapy is given to induce remission.
D) induction therapy eliminates all cancer cells
B) induction therapy reduces the leukemic cell burden.
Explanation: A) Consolidation therapy, consisting of one or more courses of high-dose chemotherapy and/or hematopoietic stem cell transplantation, is given to eradicate undetected leukemic cells so that a cure is possible.
B) Induction chemotherapy is given to induce a complete remission. Although induction therapy substantially reduces the leukemic cell burden, it is generally assumed that residual disease still exists and that some leukemic cells (fewer than 1 0 9 cells) will have survived induction therapy. This minimal residual disease is the target of consolidation therapy.
C) Induction chemotherapy is given to induce a complete remission.
D) Although induction therapy substantially reduces the leukemic cell burden, it is generally assumed that residual disease still exists and that some leukemic cells (fewer than 109 cells) will have survived induction therapy.
You might also like to view...
A client is experiencing itching and is being assessed by the nurse. The nurse notes raised reddish areas with irregular borders on the client's arm. The nurse should:
1. ask the client about sun exposure. 2. ask the client about past cancer of the skin. 3. inquire about allergies to substances. 4. ask the client how the arm got injured.
The primary purpose of priming all IV tubing before connecting it to the client is to:
a. prevent air embolism. b. ensure that an accurate dose of medication is delivered. c. aid in the solution flow through an infusion device. d. establish flow rate.
A nurse administers pure oxygen to a client during and after electroconvulsive therapy. What is the nurse's rationale for this procedure?
A. To prevent increased intracranial pressure resulting from anoxia B. To prevent hypotension, bradycardia, and bradypnea due to electrical stimulation C. To prevent anoxia due to medication-induced paralysis of respiratory muscles D. To prevent blocked airway resulting from seizure activity
A patient has undergone a primary percutaneous coronary intervention with a sirolimus-eluting stent. The provider has ordered a daily dose of 243 mg of aspirin. What will the nurse tell this patient about the dose of aspirin?
a. It will be necessary indefinitely. b. It will decrease to 81 mg per day in 6 months. c. It will decrease to 162 mg per day in 3 months. d. It will increase to 325 mg per day in 1 month.